| Vaccine approaches conferring cross-protection against influenza viruses SV Vemula, EE Sayedahmed, S Sambhara, SK Mittal Expert review of vaccines 16 (11), 1141-1154, 2017 | 70 | 2017 |
| Adenoviral vector-based vaccine platforms for developing the next generation of influenza vaccines EE Sayedahmed, A Elkashif, M Alhashimi, S Sambhara, SK Mittal Vaccines 8 (4), 574, 2020 | 60 | 2020 |
| Progress towards the development of a universal influenza vaccine WC Wang, EE Sayedahmed, S Sambhara, SK Mittal Viruses 14 (8), 1684, 2022 | 30 | 2022 |
| Current use of adenovirus vectors and their production methods EE Sayedahmed, R Kumari, SK Mittal Viral Vectors for Gene Therapy: Methods and Protocols, 155-175, 2019 | 26 | 2019 |
| A recombinant bovine adenoviral mucosal vaccine expressing mycobacterial antigen-85B generates robust protection against tuberculosis in mice A Khan, EE Sayedahmed, VK Singh, A Mishra, S Dorta-Estremera, ... Cell Reports Medicine 2 (8), 2021 | 24 | 2021 |
| Adenovirus vector-based multi-epitope vaccine provides partial protection against H5, H7, and H9 avian influenza viruses AO Hassan, O Amen, EE Sayedahmed, SV Vemula, S Amoah, I York, ... PLoS One 12 (10), e0186244, 2017 | 20 | 2017 |
| Longevity of adenovirus vector immunity in mice and its implications for vaccine efficacy EE Sayedahmed, R Kumari, S Shukla, AO Hassan, SI Mohammed, ... Vaccine 36 (45), 6744-6751, 2018 | 19 | 2018 |
| Significance of preexisting vector immunity and activation of innate responses for adenoviral vector-based therapy WC Wang, EE Sayedahmed, SK Mittal Viruses 14 (12), 2727, 2022 | 17 | 2022 |
| Adenoviral vector‐based platforms for developing effective vaccines to combat respiratory viral infections A Elkashif, M Alhashimi, EE Sayedahmed, S Sambhara, SK Mittal Clinical & Translational Immunology 10 (10), e1345, 2021 | 17 | 2021 |
| A bovine adenoviral vector-based H5N1 influenza-vaccine provides enhanced immunogenicity and protection at a significantly low dose EE Sayedahmed, AO Hassan, R Kumari, W Cao, S Gangappa, I York, ... Molecular Therapy Methods & Clinical Development 10, 210-222, 2018 | 16 | 2018 |
| Nonhuman adenoviral vector-based platforms and their utility in designing next generation of vaccines for infectious diseases M Alhashimi, A Elkashif, EE Sayedahmed, SK Mittal Viruses 13 (8), 1493, 2021 | 14 | 2021 |
| Impact of an autophagy-inducing peptide on immunogenicity and protection efficacy of an adenovirus-vectored SARS-CoV-2 vaccine EE Sayedahmed, MV Araújo, TT Silva-Pereira, SK Chothe, A Elkashif, ... Molecular Therapy-Methods & Clinical Development 30, 194-207, 2023 | 3 | 2023 |
| miRNome expression analysis in canine diffuse large B-cell lymphoma NO Elshafie, M Gribskov, NI Lichti, EE Sayedahmed, MO Childress, ... Frontiers in Oncology 13, 1238613, 2023 | 3 | 2023 |
| Nested PCR Detection of Pythium sp. from Formalin-Fixed, Paraffin-Embedded Canine Tissue Sections NO Elshafie, J Hanlon, M Malkawi, EE Sayedahmed, LF Guptill, ... Veterinary Sciences 9 (8), 444, 2022 | 3 | 2022 |
| A potential approach for assessing the quality of human and nonhuman adenoviral vector preparations EE Sayedahmed, SK Mittal Canadian Journal of Veterinary Research 84 (4), 314-318, 2020 | 3 | 2020 |
| Development of NP-Based Universal Vaccine for Influenza A Viruses EE Sayedahmed, NO Elshafie, AP Dos Santos, C Jagannath, ... Vaccines 12 (2), 157, 2024 | | 2024 |
| Enhancement of mucosal innate and adaptive immunity following intranasal immunization of mice with a bovine adenoviral vector EE Sayedahmed, NO Elshafie, GJ Zhang, SI Mohammed, S Sambhara, ... Frontiers in Immunology 14, 1305937, 2023 | | 2023 |
| Method and composition against virus infections with activated innate lymphoid cells (ilcs) M Suresh, S Sambhara, W Cao, W Mboko, E Sayedahmed US Patent App. 17/409,962, 2022 | | 2022 |
| Adenovirus Vector-based Vaccine Approach for Emerging Influenza Viruses EE Sayedahmed Purdue University, 2018 | | 2018 |
Suresh K. MittalDistinguished Professor of Virology, Purdue University在 purdue.edu 的电子邮件经过验证
